share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Real-time News ·  Jan 19, 2023 05:36

Gainers

  • Bellerophon Therapeutics (NASDAQ:BLPH) shares increased by 18.4% to $2.9 during Wednesday's after-market session. This security traded at a volume of 416.2K shares come close, making up 40.3% of its average volume over the last 100 days. The company's market cap stands at $27.6 million.
  • NanoVibronix (NASDAQ:NAOV) shares rose 12.32% to $0.36. The market value of their outstanding shares is at $11.8 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) shares moved upwards by 10.34% to $0.53. The market value of their outstanding shares is at $47.9 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) shares increased by 7.69% to $0.75. The market value of their outstanding shares is at $66.6 million.
  • Kiromic BioPharma (NASDAQ:KRBP) shares rose 7.31% to $0.22. The market value of their outstanding shares is at $4.0 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares rose 7.0% to $0.77. The company's market cap stands at $7.4 million.

Losers

  • Lyell Immunopharma (NASDAQ:LYEL) stock decreased by 6.1% to $2.81 during Wednesday's after-market session. The market value of their outstanding shares is at $699.7 million.
  • Ontrak (NASDAQ:OTRKP) stock fell 6.11% to $1.23. Today's trading volume for this security ended up closing at 51.0K shares, which is 282.2 percent of its average volume over the last 100 days.
  • Biofrontera (NASDAQ:BFRI) stock decreased by 5.26% to $0.9. The company's market cap stands at $24.0 million.
  • Seelos Therapeutics (NASDAQ:SEEL) stock declined by 5.0% to $0.93. The company's market cap stands at $99.7 million.
  • Concert Pharma (NASDAQ:CNCE) shares declined by 4.93% to $6.56. The market value of their outstanding shares is at $314.4 million.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock decreased by 4.92% to $0.58. The market value of their outstanding shares is at $27.2 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment